FDA moves to fast-track three psychedelic drugs for review

Source: NBC News Politics · Bias: Center Left

Summary

A day after the DOJ said it would ease restrictions on medical marijuana, the FDA moves to fast-track some experimental psychedelic drugs for review. They're looking at three drugs for treatment-resistant depression, major depressive disorder, and PTSD. NBC's Anne Thompson reports.

Related Coverage

Daily Analysis

Read the full Parallax Pulse for April 24, 2026 — an AI-powered analysis of how Left and Right media covered the biggest stories this day.

More Headlines From April 24, 2026

FDA moves to fast-track three psychedelic drugs for review
NBC News Politics

FDA moves to fast-track three psychedelic drugs for review

Center Left

A day after the DOJ said it would ease restrictions on medical marijuana, the FDA moves to fast-track some experimental psychedelic drugs for review. They're looking at three drugs for treatment-resistant depression, major depressive disorder, and PTSD. NBC's Anne Thompson reports.